Clinical Trial Update: Study of ILX651 in Patients With Inoperable Locally Advanced or Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial of ILX651 in inoperable locally advanced or metastatic melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• ILX651

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Melanoma | Phase 2 | Status: COMPLETED